Caloric / Dietary Restriction in Ageing

Caloric restriction (CR) means reducing caloric intake without depriving essential nutrients — described in the textbook as "nutritionally balanced semi-starvation."

Dietary restriction remains the single major intervention shown to enhance longevity across species — the reference standard against which all anti-ageing interventions are compared.

CR sits within deregulated nutrient sensing, one of the antagonistic hallmarks of ageing, alongside the insulin/IGF-1 axis, mTOR, AMPK and sirtuins.

Yeast, worms (C. elegans), flies (Drosophila) and rodents: CR reliably increases lifespan. In rodents it delays maturation and can extend lifespan by as much as 50%.

Primates: the data are conflicting. The Wisconsin group (2009) reported CR delayed disease onset and mortality in rhesus monkeys; a later study did not confirm this.

Humans: body weight below ideal is NOT associated with increased lifespan. This is the crucial translational failure point.

CR is therefore judged unlikely to be a successful intervention in humans — hence the shift to CR mimetics.

The mechanism is not fully understood but is thought to relate to reduced IGF-1 levels.

Reduced GH signalling, and reduced insulin/IGF-1, are associated with increased longevity in rodents, worms and flies.

CR lowers oxidative stress and oxidative damage and extends the maximum lifespan of rodents.

CR acts epigenetically — multiple effects on chromatin through sirtuins, TOR and other factors, making these molecules targets for lifespan extension without actual food restriction.

mTOR senses cellular nutrient levels and regulates rates of protein synthesis and energy utilisation.

Protein restriction alone works too: animals fed isocaloric diets with reduced protein have increased lifespan.

In animal models CR decreases incidence and delays onset of disease — including chronic glomerulonephritis, muscular dystrophy and carcinogenesis.

Rapamycin (mTOR inhibitor) extended lifespan in genetically heterogeneous mice even when begun in late life; the barrier to human use is immunosuppression.

Metformin is a candidate anti-ageing drug for its effects on nutrient sensing, mitochondrial dysfunction, DNA damage and inflammation.

Sirtuin activation and resveratrol produced initial excitement but were not replicated; they may extend healthspan rather than lifespan. Caloric Restriction as a Clinical Intervention in Older Adults

In overweight older adults, short-term caloric reduction improves blood pressure, cholesterol and metabolic rate — but these benefits require at least a 20% reduction in caloric intake.

Critical geriatric finding: in long-term follow-up of weight-loss RCTs, the caloric-restriction group lost more fat mass BUT ALSO more lean body mass than the exercise group, and in the long term there was no difference in physical performance between the two.

Look AHEAD: intensive lifestyle intervention maintained weight loss, fitness and CV risk factor improvement, but showed no reduction in cardiovascular events, and there was marginally greater cognitive decline in obese subjects over five years.

Improvement in comorbidities is largely independent of whether weight is actually lost — blood pressure falls with dietary change without weight loss, CAD prevention is independent of weight loss, and physical function improves without weight loss.

A randomised trial found no mortality difference between those who lost a mean of 4.4 kg and controls. Why Caloric Restriction Is Dangerous in the Old — The Counter-Argument

The anorexia of ageing means older people are already calorie-restricted involuntarily. Energy intake falls by about 30% between ages 20 and 80 (NHANES III: −1321 kcal/day in men, −629 kcal/day in women).

16–18% of community-dwelling older people already consume fewer than 1000 kcal daily.

Loss of homeostatic compensation (Roberts et al.): when young and old men were underfed by about 750 kcal/day for 21 days, the young men over-ate afterwards and rapidly regained weight; the old men did not compensate and never regained the lost weight. This is the single most important reason not to prescribe CR to older adults.

Weight loss after age 60 is disproportionately of lean tissue — up to 3 kg of lean body mass lost per decade after age 50, i.e. sarcopenia.

Unintentional weight loss of 5% or more over 6–12 months signals adverse outcomes; 10% or more very likely means protein-energy malnutrition.

Ideal weight ranges are almost certainly higher in older than in younger adults. A BMI of 25–29.9 kg/m2 carries no significant excess mortality in older adults, and BMI over 30 only about 10% excess.

Malnutrition prevalence (Mini Nutritional Assessment): overall 22.8% — rehabilitation units 50.5%, hospitalised 38.7%, community-dwelling 5.8%.

Protein-energy malnutrition is a strong independent predictor of mortality in older people, in every care setting.

CALERIE — first randomised human evidence that CR slows ageing. In a post hoc analysis of CALERIE, in which 220 adults without obesity were randomised to 25% caloric restriction or ad libitum diet for two years, the intervention slowed the pace of ageing measured by DunedinPACE, but did not significantly change PhenoAge or GrimAge. The change corresponded to roughly a 3% slowing of the pace of ageing; in independent studies a 3% slower DunedinPACE is associated with a 15% lower risk of death — described as comparable to a smoking cessation intervention. This is the first randomised evidence supporting the geroscience hypothesis in humans, and shows pace-of-ageing clocks are more sensitive to intervention than static biological-age clocks. (Nature Aging 2023)

Intermittent fasting and time-restricted eating in adults 60 and over. A 2026 systematic review and network meta-analysis of seven RCTs found moderate-certainty evidence that time-restricted eating (16:8) and intermittent Sunnah fasting produce significant reductions in body weight (ISF −2.36 kg; TRE 16:8 −1.92 kg) and BMI versus usual diet, with improvements in HbA1c and blood pressure — while calling for longer trials with longitudinal muscle mass evaluation and sarcopenia biomarkers.

The lean mass warning — directly relevant to geriatrics. An RCT in adults with overweight or obesity found a 12-week hypocaloric time-restricted eating regimen caused greater loss of lean mass than a conventional hypocaloric diet, with lean mass accounting for approximately 65% of total weight loss — far higher than the typical 20–30% with standard hypocaloric diets — leading to explicit calls for caution in those at risk of sarcopenia. A cross-sectional study of 3,680 community-dwelling Chinese adults aged 60 and over found TRE significantly associated with increased risk of severe sarcopenia, possibly because compressing the eating window concentrates protein intake and fails to provide sustained substrate for muscle protein synthesis in a population with anabolic resistance. (Frontiers in Nutrition 2025)

The protein counter-prescription. Because exercise and protein intake are the primary anabolic stimuli preserving skeletal muscle with ageing, current recommendations are to distribute protein evenly across waking hours at approximately 0.4 g/kg per meal, with a daily intake of about 1.2 g/kg/day. Any restriction protocol in an older adult must be paired with adequate protein and resistance exercise.

"Older adults do not compensate after underfeeding — unlike young adults, they do not regain the lost weight."

"Caloric restriction is a longevity strategy for the young and middle-aged; in the frail older adult the priority is the opposite — preventing undernutrition and sarcopenia."